Literature DB >> 19870882

AMOUNT AND DURATION OF IMMUNITY INDUCED BY INTRADERMAL INOCULATION OF CULTURED VACCINE VIRUS.

T M Rivers1, S M Ward, R D Baird.   

Abstract

Continued cultivation of vaccine virus in a medium consisting of minced chick embryo tissue and Tyrode's solution has resulted in a virus qualitatively changed to such an extent that considerable amounts of it can be injected intradermally into human beings without danger or inconvenience. Individuals who are vaccinated intradermally with the cultured virus should be revaccinated dermally six months to a year later with a potent calf lymph virus in order to obtain a satisfactory immunity to smallpox without being subjected to the dangers and inconvenience associated with primary vaccinations with calf lymph virus.

Entities:  

Year:  1939        PMID: 19870882      PMCID: PMC2133758          DOI: 10.1084/jem.69.6.857

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.

Authors:  T M Rivers
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

2.  JENNERIAN PROPHYLAXIS BY MEANS OF INTRADERMAL INJECTIONS OF CULTURE VACCINE VIRUS.

Authors:  T M Rivers; S M Ward
Journal:  J Exp Med       Date:  1935-09-30       Impact factor: 14.307

3.  FURTHER OBSERVATIONS ON THE CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.

Authors:  T M Rivers; S M Ward
Journal:  J Exp Med       Date:  1933-10-31       Impact factor: 14.307

  3 in total
  11 in total

1.  Species-level identification of orthopoxviruses with an oligonucleotide microchip.

Authors:  Sergey Lapa; Maxim Mikheev; Sergei Shchelkunov; Vladimir Mikhailovich; Alexander Sobolev; Vladimir Blinov; Igor Babkin; Alexander Guskov; Elena Sokunova; Alexander Zasedatelev; Lev Sandakhchiev; Andrei Mirzabekov
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  [Smallpox vaccine from tissue culture from a bull's tongue; at the same time a contribution to the question of culture vaccines].

Authors:  A HERRLICH; A MAYR
Journal:  Arch Gesamte Virusforsch       Date:  1957

3.  The production of smallpox vaccine in tissue culture of bovine embryonic skin.

Authors:  T WESSLEN
Journal:  Arch Gesamte Virusforsch       Date:  1956

4.  Primary vaccination with an attenuated strain of vaccinia virus.

Authors:  J van der Noordaa; F Dekking; J Posthuma; B J Beunders
Journal:  Arch Gesamte Virusforsch       Date:  1967

5.  Immunoprophylaxis of viral infections in childhood.

Authors:  P L Ogra
Journal:  Indian J Pediatr       Date:  1970-08       Impact factor: 1.967

Review 6.  Vaccinia virus: a suitable vehicle for recombinant vaccines?

Authors:  C Kaplan
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Vaccinia virus strain differences. II. Altered dermal reactivity of vaccinia virus by single passage in a new host system.

Authors:  R C Dunlap; L F Barker
Journal:  Arch Gesamte Virusforsch       Date:  1973

8.  Smallpox vaccination by intradermal jet injection. I. Introduction, background and results of pilot studies.

Authors:  J D Millar; R R Roberto; H Wulff; H A Wenner; D A Henderson
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

9.  Smallpox vaccination of eczema patients with attenuated live vaccinia virus.

Authors:  C H Kempe
Journal:  Yale J Biol Med       Date:  1968-08

10.  PROPAGATION OF VACCINIA VIRUS IN THE RABBIT FETUS.

Authors:  F W Gallagher; O C Woolpert
Journal:  J Exp Med       Date:  1940-07-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.